Phase 2 3 trials
Phase 2
NCT04741646 Jun 2022 → Oct 2027 expected chronic kidney disease University of California, Los Angeles
Recruiting
No outcome recorded
Phase 2
NCT01736397 Nov 2012 → Nov 2013 disorder of iron metabolism and transport , iron deficiency anemia Keryx Biopharmaceuticals
Completed
No outcome recorded
Phase 2
NCT00648167 Mar 2008 → Jan 2009 end stage renal failure , hyperphosphatemia Keryx Biopharmaceuticals
Completed
No outcome recorded
Phase 3 13 trials
Phase 3
NCT07381426 Feb → Dec 2026 expected anemia Dhaka Medical College
Not yet recruiting
No outcome recorded
Phase 3
NCT04649411 Jan 2025 → Jan 2027 iron deficiency anemia Keryx Biopharmaceuticals
Withdrawn
No outcome recorded
Phase 3
NCT04523727 Jun 2022 → Dec 2026 hyperphosphatemia Keryx Biopharmaceuticals
Suspended
No outcome recorded
Phase 3
NCT05085275 Mar 2022 → Jan 2024 cardiovascular disorder , chronic kidney disease , hyperphosphatemia , iron deficiency anemia USRC Kidney Research
Completed
No outcome recorded
Phase 3
NCT04543812 Oct 2020 → Oct 2022 anemia due to chronic disorder Panion & BF Biotech Inc.
Completed
No outcome recorded
Phase 3
NCT03984760 Jun 2019 → Feb 2021 end stage renal failure , hyperphosphatemia Panion & BF Biotech Inc.
Completed
No outcome recorded
Phase 3
NCT07522268 Jun 2019 → Jan 2021 —
Shaheed Zulfiqar Ali Bhutto Medical University
Completed
No outcome recorded
Phase 3
NCT04456803 May 2019 → Sep 2022 end stage renal failure , hyperphosphatemia Sinomune Pharmaceutical Co., Ltd
Completed
No outcome recorded
Phase 3
NCT02268994 Oct 2014 → Jan 2016 anemia due to chronic disorder Keryx Biopharmaceuticals
Completed
No outcome recorded
Phase 3
NCT01554982 Aug 2012 → Jun 2014 end stage renal failure , hyperphosphatemia , kidney failure Keryx Biopharmaceuticals
Completed
No outcome recorded
Phase 3
NCT01191255 Oct 2010 → Jan 2013 hyperphosphatemia , kidney failure Keryx Biopharmaceuticals
Completed
No outcome recorded
Phase 3
NCT01503736 Jun 2010 → Jun 2012 end stage renal failure , hyperphosphatemia Panion & BF Biotech Inc.
Completed
No outcome recorded
Phase 3
NCT01074125 May → Nov 2010 end stage renal failure , hyperphosphatemia Keryx Biopharmaceuticals
Completed
No outcome recorded
Show 3 more trials Phase 4 5 trials
Phase 4
NCT04922645 Jun 2021 → Sep 2022 hyperphosphatemia , impaired renal function disease , iron deficiency anemia USRC Kidney Research
Completed
No outcome recorded
Phase 4
NCT03055598 May 2017 → Sep 2019 overdue end stage renal failure Sreedhar Mandayam
Active not recruiting
No outcome recorded
Phase 4
NCT03079869 May 2017 → Sep 2019 hyperphosphatemia Kaiser Permanente
Completed
No outcome recorded
Phase 4
NCT03256838 Apr 2017 → Dec 2018 chronic renal failure syndrome , end stage renal failure , hyperphosphatemia Panion & BF Biotech Inc.
Completed
No outcome recorded
Phase 4
NCT02661295 Jul 2015 → Sep 2017 end stage renal failure , hyperphosphatemia , unexplained long-lasting fever/inflammatory syndrome Winthrop University Hospital
Terminated
No outcome recorded
Phase not applicable 3 trials
— NCT07120321 Jan 2022 → Jan 2025 dental caries , pulpitis Sacide Duman
Completed
No outcome recorded
— NCT02888171 Sep 2016 → Feb 2019 anemia , chronic kidney disease , disorder of iron metabolism and transport University of Alabama at Birmingham
Completed
No outcome recorded
— NCT02783911 Jan 2015 → Mar 2017 dental pulp disorder , teeth present at birth Loma Linda University
Terminated
No outcome recorded